GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » Debt-to-Equity

Navamedic ASA (FRA:N1A) Debt-to-Equity : 0.78 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA Debt-to-Equity?

Navamedic ASA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €6.12 Mil. Navamedic ASA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €8.98 Mil. Navamedic ASA's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €19.33 Mil. Navamedic ASA's debt to equity for the quarter that ended in Dec. 2023 was 0.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Navamedic ASA's Debt-to-Equity or its related term are showing as below:

FRA:N1A' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13   Med: 0.43   Max: 0.78
Current: 0.78

During the past 13 years, the highest Debt-to-Equity Ratio of Navamedic ASA was 0.78. The lowest was 0.13. And the median was 0.43.

FRA:N1A's Debt-to-Equity is ranked worse than
71.08% of 83 companies
in the Medical Distribution industry
Industry Median: 0.29 vs FRA:N1A: 0.78

Navamedic ASA Debt-to-Equity Historical Data

The historical data trend for Navamedic ASA's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA Debt-to-Equity Chart

Navamedic ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.33 0.45 0.30 0.78

Navamedic ASA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.38 0.30 0.63 0.78

Competitive Comparison of Navamedic ASA's Debt-to-Equity

For the Medical Distribution subindustry, Navamedic ASA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navamedic ASA's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's Debt-to-Equity falls into.



Navamedic ASA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Navamedic ASA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Navamedic ASA's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navamedic ASA  (FRA:N1A) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Navamedic ASA Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Navamedic ASA (FRA:N1A) Business Description

Traded in Other Exchanges
Address
Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines